Supernus Pharmaceuticals | Ventes



Sales Changement Date
Abbott USD 10.97B 370M 2024-12
ANI Pharmaceuticals USD 190.6M 42.3M 2024-12
Aurora Cannabis CAD 88.2M 7.08M 2024-12
Bristol-Myers Squibb USD 12.34B 450M 2024-12
Canopy Growth CAD 74.76M 11.77M 2024-12
Corcept Therapeutics USD 181.89M 656K 2024-12
Eisai JPY 216.14B 20.15B 2024-12
Eli Lilly USD 13.53B 2.09B 2024-12
Indivior 298M 9M 2024-12
Novo Nordisk 85.68B 14.37B 2024-12
Pacira USD 187.25M 18.68M 2024-12
Perrigo USD 1.14B 50.8M 2024-12
Pfizer USD 17.76B 61M 2024-12
Supernus Pharmaceuticals USD 174.16M 1.53M 2024-12
United Therapeutics USD 735.9M 13M 2024-12
Xeris Pharmaceuticals USD 60.1M 5.83M 2024-12



Supernus Pharmaceuticals Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.